Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abetting, acid, ACTIMMUNE, afucosylated, ago, alleviate, analyst, anticipatory, antineutrophil, artificial, artificially, Aug, automated, aware, bar, Becerra, BEKEMV, Belgium, BESPONSA, Bradner, Brazil, bulging, BUPHENYL, busch, cafraglutide, CAS, cascade, CDT, Cencora, characteristic, chemical, chemorefractory, Cheri, choice, CIO, CISO, clause, Clearwater, clinician, CMO, colon, Columbia, contraindicated, conventional, conversion, CRC, CRCC, CTO, curb, cyber, Daxdilimab, Dazodalibep, debilitating, Dec, Deerfield, dendritic, Denmark, diffuse, digital, diplopia, discoid, disorder, diverging, doser, DTI, duty, earliest, eleven, encountered, entirety, ERBITUX, Erroneously, evade, Farmaceutico, fiduciary, fight, Fipaxalparant, FL, flare, forensic, frontline, furthest, gas, gave, Gaza, gender, German, gout, greatest, greenhouse, hardware, harmonize, Harvard, hyperthyroidism, idiopathic, IL, impasse, inaugural, inopportune, Inspire, IP, irreversible, isatuximab, ISDA, Israel, iterative, judgement, justify, kappa, KRYSTEXXA, Laboratorio, layered, legacy, Lek, Leon, LEQVIO, Ltda, lysophosphatidic, maridebart, Martin, matthew, mCRC, mechanism, mentorship, Merck, metric, misalignment, misconfiguration, misleading, mismanagement, mOS, multidimensional, Munich, myasthenia, Nevada, nontraditional, Nullity, OPDIVO, operationally, optica, Organisation, organizational, orphan, oxidase, Parliament, PBM, pegloticase, PENNSAID, pension, PMR, PREA, predecessor, pretrial, proceed, PROCYSBI, proficiency, prove, PSU, purportedly, Pushtronex, Quimico, QUINSAIR, race, racial, RAS, RAVICTI, reargument, rectum, regime, regorafenib, RI, sat, satisfactory, SCLC, SOTYKTU, specialist, spectrum, stack, stopgap, struck, Tampa, team, TED, TEPEZZA, tighter, tipiracil, Topical, toughest, trifluridine, tyler, unaffordable, unified, unjust, unrelated, unremitted, UPLIZNA, upskilling, uric, UTB, viability, vision, weak, Wezlana, xanthine
Removed:
accomplishment, accreted, affirmative, affirming, Alendronate, alirocumab, Alkem, allegation, amending, Amneal, ANDA, Anderson, Annora, antiresorptive, Apotex, Aurobindo, Aventisub, avoid, BAFF, belief, Biden, BioVex, black, border, breakaway, brodalumab, Businesswomen, cancellation, certiorari, chance, closed, coalition, college, column, concurrently, conjugate, consultation, count, counting, dedesignate, dental, deplete, disagree, discontinue, discounting, discovering, disputing, disruptive, distancing, doctor, door, DRL, ease, ebb, Emcure, employing, enablement, enduring, ESA, exacerbated, exchanged, experiencing, failing, fever, filgrastim, fluidity, formula, founding, Fulphila, fungible, genital, Glenmark, governed, grantee, Heritage, Hetero, holding, hospital, ICOSL, immunogenicity, immunosuppressive, importing, improved, infection, Institutional, instructing, insulin, issuable, judgmental, jury, leaving, linda, lookback, Los, louie, magnitude, Mankind, MBA, Methotrexate, mind, minimize, modification, monetization, MSN, navigate, neuroscience, noncancelable, notify, Nucleic, occupancy, OneTen, onset, optional, ordered, outbreak, overturning, pegylated, penalize, pendency, Pharmascience, phased, prediction, Prinston, producing, proteasome, raloxifene, reallocation, reassessment, receivable, recruiting, rehearing, reimpose, reinstate, reinstatement, remand, replace, resurgence, returned, Rozibafusp, selecting, Shilpa, skill, spent, stayed, stemming, stipulated, substituting, successor, surge, temperature, tendered, tentative, terminating, timeline, Torrent, trajectory, transition, trip, UDENYCA, unanimously, unapproved, unavailability, underrepresentation, Unichem, unlocking, unravel, ustekinumab, vaccination, validly, verdict, wider, worked, worsen, writ
Filing tables
Filing exhibits
- 10-K Annual report
- 4.33 Description of Securities
- 10.2 Form of Grant of Stock Option Agreement
- 10.3 Form of Restricted Stock Unit Agreement
- 10.5 Form of Performance Unit Agreement
- 10.6 Amgen Inc. 2009 Director Equity Incentive Program
- 10.9 Fifth Amendment to Supplemental Retirement Plan
- 10.12 Fourth Amendment to Nonqualified Deferred Compensation Plan
- 10.14 Agreement Between Amgen Inc. and James Bradner
- 10.17 Collaboration and License Agreement Between Amgen Inc. and Celltech R&D Limited
- 10.17 Amendment No 2 to Celltech Collaboration and License Agreement
- 10.22 Letter Agreement Re Fte Rates
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
- 97 Policy on Recovery of Erroneously Awarded Compensation
- Download Excel data file
- View Excel data file
Related press release
Associated AMGN transcripts
AMGN similar filings
Filing view
External links